These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 2385834)
1. Down-regulation of muscarinic receptors in the striatum of organophosphate-treated swine. Yang CM; Dwyer TM; Mohan PM; Ho IK; Farley JM Toxicol Appl Pharmacol; 1990 Jul; 104(3):375-85. PubMed ID: 2385834 [TBL] [Abstract][Full Text] [Related]
2. Changes in affinity states during down-regulation of muscarinic receptors in tracheal smooth muscle of organophosphate-treated swine. Yang CM; Mohan PM; Dwyer TM; Farley JM J Auton Pharmacol; 1988 Jun; 8(2):79-91. PubMed ID: 3170629 [TBL] [Abstract][Full Text] [Related]
3. Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle. Yang CM; Farley JM; Dwyer TM J Auton Pharmacol; 1986 Mar; 6(1):15-24. PubMed ID: 3957950 [TBL] [Abstract][Full Text] [Related]
4. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates. Galper JB; Dziekan LC; O'Hara DS; Smith TW J Biol Chem; 1982 Sep; 257(17):10344-56. PubMed ID: 7107608 [TBL] [Abstract][Full Text] [Related]
5. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397 [TBL] [Abstract][Full Text] [Related]
6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581 [TBL] [Abstract][Full Text] [Related]
8. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors. Das S; Matwyshyn GA; Bhargava HN Peptides; 1986; 7(1):21-5. PubMed ID: 2872660 [TBL] [Abstract][Full Text] [Related]
9. Muscarinic stimulation of submucosal glands in swine trachea. Yang CM; Farley JM; Dwyer TM J Appl Physiol (1985); 1988 Jan; 64(1):200-9. PubMed ID: 3356638 [TBL] [Abstract][Full Text] [Related]
10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
11. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine. Yamada S; Isogai M; Okudaira H; Hayashi E J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862 [TBL] [Abstract][Full Text] [Related]
12. Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropine. Yamada S; Isogai M; Okudaira H; Hayashi E Brain Res; 1983 Jun; 268(2):315-20. PubMed ID: 6871685 [TBL] [Abstract][Full Text] [Related]
13. [Effects of diisopropylfluorophosphate, paraoxon and dichlophos on [3H] quinuclidinyl benzylate binding to the rat striatum synaptic membranes]. Golovko AI; Sofronov GA; Nikolaeva TV; Kliuntina TV Biull Eksp Biol Med; 1992 Sep; 114(9):290-1. PubMed ID: 1477363 [TBL] [Abstract][Full Text] [Related]
14. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. Watson M; Yamamura HI; Roeske WR Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants. Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173 [TBL] [Abstract][Full Text] [Related]
16. Contractile responses of tracheal smooth muscle in organophosphate-treated swine: 1. Agonist changes. Murali Mohan P; Huang Saunders HM; Yang CM; Dwyer TM; Farley JM J Auton Pharmacol; 1988 Jun; 8(2):93-106. PubMed ID: 2902099 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy. Monsma FJ; Abood LG; Hoss W Biochem Pharmacol; 1988 Jun; 37(12):2437-43. PubMed ID: 2839194 [TBL] [Abstract][Full Text] [Related]
18. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue. Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989 [TBL] [Abstract][Full Text] [Related]
19. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB; Creese I Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [TBL] [Abstract][Full Text] [Related]
20. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex. Adem A; Sabbagh M; Nordberg A J Neural Transm; 1988; 72(1):11-8. PubMed ID: 3379385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]